SynAct Pharma AB (STO: SYNACT)
8.83
+1.11 (14.30%)
Aug 30, 2024, 5:29 PM CET
SynAct Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 4.99 | 22.03 | 32.04 | 28.84 | 55.98 | 33.73 | Upgrade
|
Cash & Short-Term Investments | 4.99 | 22.03 | 32.04 | 28.84 | 55.98 | 33.73 | Upgrade
|
Cash Growth | -86.37% | -31.25% | 11.11% | -48.49% | 65.94% | -20.35% | Upgrade
|
Other Receivables | 0.46 | 0.64 | 0.84 | 0.7 | 0.44 | 0.27 | Upgrade
|
Receivables | 0.46 | 0.64 | 0.84 | 0.7 | 0.44 | 0.27 | Upgrade
|
Prepaid Expenses | 3.36 | 2.64 | 0.47 | 0.5 | 0.07 | 0.11 | Upgrade
|
Total Current Assets | 8.81 | 25.3 | 33.34 | 30.04 | 56.49 | 34.11 | Upgrade
|
Other Intangible Assets | 1.63 | 1.63 | 1.63 | 1.63 | 1.63 | 1.63 | Upgrade
|
Long-Term Deferred Charges | 101.96 | 96.25 | 76.65 | 60.02 | 42.69 | 27.8 | Upgrade
|
Other Long-Term Assets | 0 | - | - | - | - | - | Upgrade
|
Total Assets | 112.4 | 123.19 | 111.62 | 91.69 | 100.82 | 63.53 | Upgrade
|
Accounts Payable | 2.25 | 2.49 | 3.17 | 0.79 | 1.91 | 0.43 | Upgrade
|
Accrued Expenses | 2.05 | 2.63 | 1.4 | 1.06 | 1.57 | 2.64 | Upgrade
|
Other Current Liabilities | 3.29 | 3.41 | 0.72 | 0.57 | 0.51 | 0.56 | Upgrade
|
Total Current Liabilities | 7.58 | 8.53 | 5.29 | 2.42 | 3.99 | 3.62 | Upgrade
|
Long-Term Debt | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | Upgrade
|
Total Liabilities | 8.38 | 9.33 | 6.09 | 3.22 | 4.79 | 4.42 | Upgrade
|
Common Stock | 11.71 | 11.71 | 8.53 | 4.15 | 4.15 | 2.01 | Upgrade
|
Additional Paid-In Capital | 166.26 | 166.26 | 144.65 | 118.87 | 118.87 | 77.6 | Upgrade
|
Retained Earnings | -73.96 | -64.12 | -47.64 | -34.55 | -27 | -20.5 | Upgrade
|
Shareholders' Equity | 104.02 | 113.86 | 105.53 | 88.47 | 96.02 | 59.11 | Upgrade
|
Total Liabilities & Equity | 112.4 | 123.19 | 111.62 | 91.69 | 100.82 | 63.53 | Upgrade
|
Total Debt | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | Upgrade
|
Net Cash (Debt) | 4.19 | 21.23 | 31.24 | 28.04 | 55.18 | 32.93 | Upgrade
|
Net Cash Growth | -88.30% | -32.05% | 11.42% | -49.19% | 67.54% | -20.74% | Upgrade
|
Net Cash Per Share | 0.09 | 0.53 | 1.29 | 1.78 | 3.48 | 4.31 | Upgrade
|
Filing Date Shares Outstanding | 44.53 | 44.53 | 32.42 | 15.78 | 15.78 | 7.63 | Upgrade
|
Total Common Shares Outstanding | 44.53 | 44.53 | 32.42 | 15.78 | 15.78 | 7.63 | Upgrade
|
Working Capital | 1.23 | 16.77 | 28.05 | 27.62 | 52.5 | 30.49 | Upgrade
|
Book Value Per Share | 2.34 | 2.56 | 3.26 | 5.61 | 6.09 | 7.74 | Upgrade
|
Tangible Book Value | 102.39 | 112.23 | 103.9 | 86.84 | 94.39 | 57.48 | Upgrade
|
Tangible Book Value Per Share | 2.30 | 2.52 | 3.20 | 5.50 | 5.98 | 7.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.